Key clinical point: Topical gentamicin heals lesions of inherited Herlitz junctional epidermolysis bullosa (H-JEB), validating in vitro activity.
Major finding: Lesion healing correlates with increased production of laminin 332, the key underlying defect of H-JEB.
Data Source: Pilot study.
Disclosures: Mr. Kwong reports no potential conflicts of interest.
Kwong A. SID 2019;S102, Abstract 594. 77th Annual Meeting of the Society for Investigative Dermatology.